[go: up one dir, main page]

TN2009000008A1 - Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination - Google Patents

Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination

Info

Publication number
TN2009000008A1
TN2009000008A1 TN2009000008A TN2009000008A TN2009000008A1 TN 2009000008 A1 TN2009000008 A1 TN 2009000008A1 TN 2009000008 A TN2009000008 A TN 2009000008A TN 2009000008 A TN2009000008 A TN 2009000008A TN 2009000008 A1 TN2009000008 A1 TN 2009000008A1
Authority
TN
Tunisia
Prior art keywords
serotonin
recapture
inhibitor
combination
norepinephrine
Prior art date
Application number
TN2009000008A
Other languages
English (en)
Inventor
Guy Griebel
Caroline Cohen
Caroline Louis
Lisa Arvanitis
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0607050A external-priority patent/FR2904221B1/fr
Priority claimed from FR0700863A external-priority patent/FR2912057B1/fr
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of TN2009000008A1 publication Critical patent/TN2009000008A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
TN2009000008A 2006-07-31 2009-01-14 Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination TN2009000008A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0607050A FR2904221B1 (fr) 2006-07-31 2006-07-31 Composition pharmaceutique contenant en association le saredutant et la fluoxetine.
FR0700863A FR2912057B1 (fr) 2007-02-07 2007-02-07 Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
PCT/FR2007/001314 WO2008017753A2 (fr) 2006-07-31 2007-07-30 Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine

Publications (1)

Publication Number Publication Date
TN2009000008A1 true TN2009000008A1 (en) 2010-08-19

Family

ID=39001699

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2009000008A TN2009000008A1 (en) 2006-07-31 2009-01-14 Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination

Country Status (23)

Country Link
US (2) US20080033014A1 (fr)
EP (1) EP2049093A2 (fr)
JP (1) JP2009545573A (fr)
KR (1) KR20090034368A (fr)
AR (1) AR062142A1 (fr)
AU (1) AU2007283530A1 (fr)
BR (1) BRPI0714862A2 (fr)
CA (1) CA2658614A1 (fr)
CL (1) CL2007002217A1 (fr)
CO (1) CO6150152A2 (fr)
CR (1) CR10579A (fr)
EA (1) EA200970167A1 (fr)
EC (1) ECSP099093A (fr)
GT (1) GT200900018A (fr)
IL (1) IL196570A0 (fr)
MA (1) MA30645B1 (fr)
MX (1) MX2009001219A (fr)
NO (1) NO20090924L (fr)
PE (1) PE20080431A1 (fr)
TN (1) TN2009000008A1 (fr)
TW (1) TW200817003A (fr)
UY (1) UY30517A1 (fr)
WO (1) WO2008017753A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20140045936A1 (en) * 2011-04-21 2014-02-13 Wake Forest University Health Sciences Cyclopropyl derivatives and methods of use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
NL7503310A (nl) * 1975-03-20 1976-09-22 Philips Nv Verbindingen met antidepressieve werking.
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
FR2508035A1 (fr) * 1981-06-23 1982-12-24 Fabre Sa Pierre Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US4902710A (en) * 1988-12-14 1990-02-20 Eli Lilly And Company Serotonin and norepinephrine uptake inhibitors
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical compositions containing them
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
AU4918796A (en) * 1995-02-10 1996-08-27 Eli Lilly And Company Methods of treating or preventing psychiatric disorders
FR2792835B3 (fr) * 1999-04-27 2001-05-25 Sanofi Sa Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
WO2007047576A1 (fr) * 2005-10-14 2007-04-26 The Board Of Trustees Of The University Of Illinois Traitements pharmacologiques contre des troubles du sommeil
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine

Also Published As

Publication number Publication date
JP2009545573A (ja) 2009-12-24
CL2007002217A1 (es) 2008-03-07
PE20080431A1 (es) 2008-05-26
US20080033014A1 (en) 2008-02-07
NO20090924L (no) 2009-03-18
EP2049093A2 (fr) 2009-04-22
MA30645B1 (fr) 2009-08-03
CR10579A (es) 2009-03-20
US20090227632A1 (en) 2009-09-10
CA2658614A1 (fr) 2008-02-14
EA200970167A1 (ru) 2009-08-28
BRPI0714862A2 (pt) 2013-07-02
WO2008017753A3 (fr) 2009-02-19
KR20090034368A (ko) 2009-04-07
MX2009001219A (es) 2009-02-13
CO6150152A2 (es) 2010-04-20
AU2007283530A1 (en) 2008-02-14
IL196570A0 (en) 2009-11-18
AR062142A1 (es) 2008-10-15
TW200817003A (en) 2008-04-16
GT200900018A (es) 2010-08-23
UY30517A1 (es) 2008-02-29
WO2008017753A2 (fr) 2008-02-14
ECSP099093A (es) 2009-02-27

Similar Documents

Publication Publication Date Title
DK2049513T3 (da) Piperidinylsubstituerede pyrrolidinoner som inhibitorer af 11-beta-hydroxysteroiddehydrogenase 1
IL186112A0 (en) SUBSTITUTED HETEROCYCLES AND THEIR USE AS CHK1, PDK1 AND Pak INHIBITORS
SI2049475T1 (sl) Pirolidinoni substituirani s cikloheksilom kot inhibitorji 11-betahidroksisteroid dehidrogenaze 1
IL187311A0 (en) N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
NZ594597A (en) Substituted piperidines as ccr3 antagonists
ZA200705839B (en) Cyclohexylamides as dopamine D3, D2 and 5HT1A antagonists
MY161461A (en) Akt and p70 s6 kinase inhibitors
PL2139479T3 (pl) 4-[2-(4-Metylofenylosulfanylo)fenylo]piperydyna o połączonym hamowaniu wychwytu zwrotnego serotoniny i norepinefryny do leczenia ADHD, melancholii, depresji opornej na leczenie lub pozostałych objawów depresji
IL179371A0 (en) 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
TN2009000091A1 (en) Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors
WO2008087654A3 (fr) PIPÉRIDINES EN TANT QU&#39;INHIBITEURS DE 11β-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE DE TYPE 1
TN2009000008A1 (en) Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination
WO2005123679A3 (fr) Nouveaux derives de piperidine substitues par alkyle et leur utilisation comme inhibiteurs de recaptage de neurotransmetteur de monoamine
PT1613594E (pt) Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inibidores da recaptação da serotonina
WO2007026219A3 (fr) Composition d&#39;antagonistes du recepteur 5-ht1b servant au traitement d&#39;etats du systeme nerveux central
WO2011084652A3 (fr) Sels et formes cristallines d&#39;inhibiteur de facteur xa
TW200603803A (en) Novel compounds
IL183191A0 (en) N-[(3s)-pyrrolidin-3-yl]-benzamide derivatives as monoamine re-uptake inhibitors
HK1124042A (en) Pyrimido- [4, 5-]-oxazines for use as dgat inhibitors
TW200744571A (en) Combination of β3 receptor agonist and of monoamine reuptake inhibitors, pharmaceutical composition containing it and therapeutic use thereof
PE20131129A1 (es) Compuestos heteroaril-aril-ureas como inhibidores de la quinasa
HK1114092A (en) Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
TW200617170A (en) Ready-for-complexation composition
HK1105277A (en) 4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
SI2029529T1 (sl) Substituirani pirolidinoni kot inhibitorji 11-beta-hidroksisteroid dehidrogneaze 1